BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11500410)

  • 1. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.
    Tanghe A; Content J; Van Vooren JP; Portaels F; Huygen K
    Infect Immun; 2001 Sep; 69(9):5403-11. PubMed ID: 11500410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
    Hart BE; Hale LP; Lee S
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004046. PubMed ID: 26393347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer.
    Coutanceau E; Legras P; Marsollier L; Reysset G; Cole ST; Demangel C
    Microbes Infect; 2006 Jul; 8(8):2075-81. PubMed ID: 16781179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.
    Hart BE; Lee S
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005229. PubMed ID: 27941982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
    Tanghe A; Adnet PY; Gartner T; Huygen K
    Infect Immun; 2007 May; 75(5):2642-4. PubMed ID: 17325046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting.
    Tanghe A; Dangy JP; Pluschke G; Huygen K
    PLoS Negl Trop Dis; 2008 Mar; 2(3):e199. PubMed ID: 18350112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease.
    Portaels F; Aguiar J; Debacker M; Guédénon A; Steunou C; Zinsou C; Meyers WM
    Infect Immun; 2004 Jan; 72(1):62-5. PubMed ID: 14688081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice.
    Roupie V; Pidot SJ; Einarsdottir T; Van Den Poel C; Jurion F; Stinear TP; Huygen K
    PLoS Negl Trop Dis; 2014; 8(1):e2604. PubMed ID: 24392169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans.
    Diaz D; Döbeli H; Yeboah-Manu D; Mensah-Quainoo E; Friedlein A; Soder N; Rondini S; Bodmer T; Pluschke G
    Clin Vaccine Immunol; 2006 Dec; 13(12):1314-21. PubMed ID: 17021247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).
    Portaels F; Aguiar J; Debacker M; Steunou C; Zinsou C; Guédénon A; Meyers WM
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1389-91. PubMed ID: 12414782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva.
    Marsollier L; Deniaux E; Brodin P; Marot A; Wondje CM; Saint-André JP; Chauty A; Johnson C; Tekaia F; Yeramian E; Legras P; Carbonnelle B; Reysset G; Eyangoh S; Milon G; Cole ST; Aubry J
    PLoS Med; 2007 Feb; 4(2):e64. PubMed ID: 17326707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease.
    Dobos KM; Spotts EA; Marston BJ; Horsburgh CR; King CH
    Emerg Infect Dis; 2000; 6(2):158-64. PubMed ID: 10756149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
    Converse PJ; Almeida DV; Nuermberger EL; Grosset JH
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e985. PubMed ID: 21423646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.
    Prévot G; Bourreau E; Pascalis H; Pradinaud R; Tanghe A; Huygen K; Launois P
    Infect Immun; 2004 Feb; 72(2):958-65. PubMed ID: 14742541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
    Bolz M; Bénard A; Dreyer AM; Kerber S; Vettiger A; Oehlmann W; Singh M; Duthie MS; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004431. PubMed ID: 26849213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buruli ulcer.
    Einarsdottir T; Huygen K
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease.
    Cope RB; Stang B; Valentine BA; Bermudez LE
    Photodermatol Photoimmunol Photomed; 2004 Feb; 20(1):14-20. PubMed ID: 14738528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.